Eurocor - Life Sciences Technologies Interventional Cardiology Devices Endovascular Therapies

Dediacted to Your heart.
Life Sciences Technology.
Coronary stent technologies and special cardiovascular and endovascluar devices made in Europe for the world.

CIRSE 2017 in Copenhagen

Date: 2017/09/15

From September 16th – 20th 2017 CIRSE congress is about to take place in Copenhagen, Denmark. CIRSE congress is the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe.
 
Further information on http://cirse.org/index.php?pid=1327


Eurocor is proud to announce the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

CIRSE

EUROCOR SCIENTIFIC PROGRAM

Titel: The randomized Freeway Stent Study completed the 12-month follow-up and favored the use of drug-eluting balloons over plain balloons for the postdilatation of nitinol stents in the SFA and PI segments to lower restenosis rate

Session: FP 2306 - Peripheral arterial disease
Date: Monday Sept. 18, 2017
Time: 17.30 – 18.30
Place: Auditorium 11

There will also be an electronic Poster by Dr. Troisi about Freeway in AV Shunt



The Freeway Stent Study was lead-managed by Prof. Dr. Josef Tacke, Klinikum Passau, Germany. The multicenter, open, prospective randomized study investigated the prevention of restenosis in the treatment of Superficial Femoral Artery (SFA) or Popliteal artery (PI-segment) lesions in the legs. The study examined whether implantation of a Nitinol stent followed by post-dilatation with a drug-eluting balloon (DEB) FREEWAYTM is advantageous over Nitinol stenting and post-dilatation by a plain balloon (POBA). The study was conducted in 13 sites in Germany and Austria. 204 patients suffering from de novo lesions that needed to be stented were enrolled and randomized in a 1:1 ratio. Patients have been followed at 6 and 12 months.


Copenhagen

The Company:

Eurocor is a rapidly growing European Life Sciences Technology Corporation specializing in the research, development and manufacture of cardiovascular and endovascular products. Eurocor provides interventional physicians with innovative coronary stent technologies and special cardiovascular and endovascular devices, manufactured in Europe. Products are indicated for minimally cardiovascular and peripheral surgery and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions. Extensive research and development, close clinician collaboration, outstanding quality standard philosophy and global scientific alliances lead to optimization of clinically effective technologies. Eurocor has designed an innovative method for balloon catheter drug delivery with high patient compliance. One heartbeat ahead® – with innovative products such as DIOR® and FREEWAY™.

Eurocor GmbH is a wholly owned subsidiary of Opto Eurocor Healthcare Limited and is part of Opto Circuits Group

For more information, please visit eurocor.de and optocircuits.com